Gangnam Severance Hospital Begins Its DYNAPEX PLATFORM Subscription

Gangnam Severance Hospital has begun its DYNAPEX PLATFORM subscription. On April 30, 2026, Gangnam Severance Hospital adopted DYNAPEX PLATFORM to use brain imaging AI analysis solutions within a unified platform environment.

The subscription covers DYNAPEX’s core products (DYNAPEX BT, DYNAPEX METS, DYNAPEX AD, and DYNAPEX PD) along with partner plug-ins CERCARE NEUROSUITE and NEUROPHET AQUA. This enables clinical teams to use multiple brain imaging AI analysis solutions within the DYNAPEX PLATFORM environment.

DYNAPEX will keep adding platform subscriptions at leading hospitals and continue building out its products and partner network for integrated, precise brain-imaging AI.